Literature DB >> 7226112

Reassessment of prognostic factors in stage IIIA and IIIB Hodgkin's disease treated with MOPP and radiotherapy.

R W Rodgers, L M Fuller, F B Hagemeister, D A Johnston, J A Sullivan, L B North, J J Butler, W S Velasquez, F G Conrad, C C Shullenberger.   

Abstract

Prognostic factors have been re-evaluated for 88 patients with Stage III Hodgkin's disease to see if they have remained significant on a long-term basis. Treatment had consisted of two cycles of MOPP followed by radiotherapy to the mantle, abdomen, and pelvis; all patients had achieved complete remission. Case material was grouped according to the presence of absence of mediastinal disease. Five-year survivals for Stage IIIA and IIIB patients were 85 and 80%; corresponding disease-free survivals were 76 and 73%. Significant prognostic factors include age, histopathology, and extent of abdominal disease, but the relative importance of these factors differs for the mediastinal and nonmediastinal patients. Modifications of current treatment policy for both mediastinal and nonmediastinal patients are discussed in relation to the prognostic factors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7226112     DOI: 10.1002/1097-0142(19810501)47:9<2196::aid-cncr2820470915>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Radiation therapy alone versus radiation therapy and chemotherapy in the management of Hodgkin's disease.

Authors:  L D Glenn; P P Kumar
Journal:  J Natl Med Assoc       Date:  1990-02       Impact factor: 1.798

Review 2.  Current approaches to the treatment of advanced-stage Hodgkin's disease.

Authors:  J J Rusthoven
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

3.  Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy.

Authors:  B F Brandriff; M L Meistrich; L A Gordon; A V Carrano; J C Liang
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

4.  Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres.

Authors:  J Wagstaff; W M Gregory; R Swindell; D Crowther; T A Lister
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.